NCT02286934View on ClinicalTrials.gov

Cytochrome P450 2D6 Genotype on the Clinical Effect of Carvedilol

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy
Interventions
DRUG

Carvedilol

"* Day 1 to 3 : Carvedilol 12.5 mg qd~* Day 4 to 8 : Carvedilol 25 mg qd~* Day 9 to 11 : Carvedilol 12.5 mg qd"

OTHER

Isoproterenol Sensitivity Test

Day 0, 1, 8 : Isoproterenol Sensitivity Test

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Seongnam

All Listed Sponsors
collaborator

National Institute of Food and Drug Safety Evaluation, Korea

UNKNOWN

lead

Seoul National University Hospital

OTHER

NCT02286934 - Cytochrome P450 2D6 Genotype on the Clinical Effect of Carvedilol | Biotech Hunter | Biotech Hunter